{"database": "openregs", "table": "documents", "rows": [["FDA-2013-D-0576-0022", "FDA", "FDA-2013-D-0576", "Reference 2 Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications re Considerations for the Design of Early-Phase Clinical Trials of Cellular and Gene Therapy Products; Guidance for Industry", "Supporting & Related Material", "Background Material", "2015-06-11T04:00:00Z", 2015, 6, null, null, "2015-06-11T14:25:22Z", null, 0, 0, "0900006481b2cdce"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-D-0576-0022"], "units": {}, "query_ms": 157.3228258639574, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}